Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-06-06

Clinical Trial Update: Effectiveness of Atypical Versus Conventional Antipsychotics in Treating Schizophrenia [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing atypical versus conventional antipsychotics for schizophrenia has completed. The brief does not include the study results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Yale University | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED